Metraipolis › archive › dc_d3cc830ea5d1

Drug combination choices of 5α-reductase inhibitors and α-blockers in patients with benign prostatic hyperplasia: a study based on the FAERS database — Europe PMC PMID:42375193

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42375193
DOI
10.3389/fmed.2026.1870053
License (as archived)
solo-consultazione
Archived
2026-10-09T22:44:36.508Z
SHA-256 of the archived text
2c16b5cc2225cc124271bb0fb02d9bcbc93af2aa968a0e2c67f7703fe7af7bdf
Stable URL of this page
https://metraipolis.com/documento/dc_d3cc830ea5d1

How to cite

Drug combination choices of 5α-reductase inhibitors and α-blockers in patients with benign prostatic hyperplasia: a study based on the FAERS database — Europe PMC PMID:42375193 — Europe PMC (en), https://europepmc.org/article/MED/42375193 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d3cc830ea5d1 (Metraipolis archive dc_d3cc830ea5d1, sha256 2c16b5cc2225cc124271bb0fb02d9bcbc93af2aa968a0e2c67f7703fe7af7bdf)
BibTeX
@misc{dcd3cc830ea5d1,
  title = {Drug combination choices of 5α-reductase inhibitors and α-blockers in patients with benign prostatic hyperplasia: a study based on the FAERS database — Europe PMC PMID:42375193},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42375193},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d3cc830ea5d1; sha256 2c16b5cc2225cc124271bb0fb02d9bcbc93af2aa968a0e2c67f7703fe7af7bdf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42375193. Agents can read the archived copy with the MCP tool read_document.